NewBridge Pharmaceuticals
Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.
NewBridge Pharmaceuticals operates in biotechnology, medical device, oncology, pharmaceutical based in Europe, Middle East, and Africa (EMEA), Gulf Cooperation Council (GCC), Middle East, Middle East and North Africa (MENA), founded in 2007.
Its activity falls under biotechnology, medical device, oncology, pharmaceutical; the profile below is assembled from public directory data.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA), Gulf Cooperation Council (GCC), Middle East, Middle East and North Africa (MENA).
It is recorded at the Series_C stage.
The company reports a headcount in the c_00051_00100 range.
Total disclosed funding stands at about $60M.
| Sector | Biotechnology, Medical Device, Oncology, Pharmaceutical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Gulf Cooperation Council (GCC), Middle East, Middle East and North Africa (MENA) |
| Founded | 2007 |
| Employees | c_00051_00100 |
| Stage | series_c |
| Total funding | $60,000,000 |
Website: www.nbpharma.com
Browse related
Create a free account